Nautilus Biotechnology, Inc. NAUT
Set alert
2.34 USD -0.40 -14.47%
At close · Nov 2
2.36 +0.02 +1.07%
After hours · Nov 2, 7:59 PM ET
2.27 Day range 2.75
0.852 52-week range 3.95
- YTD
- +19.74%
- 1 year
- +75.56%
- Open
- 2.74
- Prev close
- 2.73
- Mkt cap
- 297.41M
- Vol
- 7.30M
- Avg vol
- 5.35M
- EPS
- -0.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.27
- High
- 2.75
- Forward P/E
- -2.32
- Beta
- 1.04
- Short ratio
- 9.26
- Inst. own
- 50.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 30, 2024
- 50-d avg
- 2.42
- 200-d avg
- 2.56
- 1y target
- 3.44
5D chart
Signals (98)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2:35 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 11:45 AM | 15 hours ago |
| SMA: Bearish | Nov 2, 11:45 AM | 15 hours ago |
| SMA: Bullish | Nov 2, 11:40 AM | 15 hours ago |
| SMA: Bullish | Nov 2, 11:15 AM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 11:15 AM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 10:40 AM | 16 hours ago |
| SMA: Bearish | Nov 2, 10:35 AM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 10:25 AM | 16 hours ago |
| SMA: Bullish | Nov 2, 10:05 AM | 17 hours ago |
| RSI: Oversold | Nov 2, 9:35 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 9:30 AM | 17 hours ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:40 PM | 3 days ago |
Newest 20 of 98.
Analyst view
Consensus: buy
Buy
Price target (mean) 3.44 +47.2% upside
Now 2.34
- Target (low)
- 1.75
- Target (mean)
- 3.44
- Target (high)
- 5.00
Ratings (0m) 5 2 buy · 2 hold · 1 sell
- Strong buy0
- Buy2
- Hold2
- Sell0
- Strong sell1
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.16333 | -0.18 – -0.15 | -0.14 | -16.7% | 0 | 0.0% | 3 |
| Next quarter | -0.18 | -0.20 – -0.15 | -0.15 | -20.0% | 0 | 0.0% | 3 |
| Current year | -0.58333 | -0.60 – -0.57 | -0.51 | -14.4% | 0 | 0.0% | 3 |
| Next year | -0.74333 | -0.84 – -0.66 | -0.58333 | -27.4% | 3.62M | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Goldman Sachs | Downgrade | Neutral | Sell |
| Jun 27, 2024 | Guggenheim | Initiated | — | Buy |
| Aug 3, 2023 | Morgan Stanley | Reiterated | Equal-Weight | Equal-Weight |
| Aug 3, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Aug 3, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Jul 14, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Apr 13, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Jan 6, 2022 | Morgan Stanley | Initiated | — | Equal-Weight |
| Nov 2, 2021 | Cowen & Co. | Initiated | — | Outperform |
| Aug 4, 2021 | Goldman Sachs | Initiated | — | Neutral |
| Jul 13, 2021 | Jefferies | Initiated | — | Buy |